| abstract |
Disclosed is a compound having excellent FATP4 inhibitory activity. Specifically disclosed is a five-membered heterocyclic compound represented by formula (I) or a pharmaceutically acceptable salt thereof. In formula (I), A represents -CO- or -CH2-; X represents -CH2-, -O- or -NH-; Y and W may be the same or different and each represents formula (II) or formula (III); Ar represents formula (IV) or the like; and R1 represents -CO-NR6R7, -CO2-R8, -NHCO-R9 or the like. |